Oral administration of 2.5 mg luseogliflozin once a day, pre or post breakfast for 52 weeks
Sponsors
Seino Internal Medicine Clinic, Abe Diabetes Clinic
Conditions
Type 2 diabetesType 2 diabetes mellitus
Unknown Phase
Efficacy and safety of luseogliflozin in patient with type 2 diabetes complicated with hepatic dysfunction
Active, not recruitingJPRN-UMIN000025808
Start: 2017-01-23Target: 50Updated: 2026-06-29
The effect of SGLT2 inhibitor on glomrular hyperfiltration in type 2 diabetes patients.
Active, not recruitingJPRN-UMIN000026887
Start: 2017-04-10Target: 30Updated: 2026-06-29